Integrated BioPharma, Inc. (INBP)
OTCMKTS: INBP · Delayed Price · USD
0.191
-0.019 (-9.10%)
May 2, 2024, 2:46 PM EDT - Market closed
Integrated BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 6 | 10 | 15 | 33 | 13 | 5 | 5 | 4 | 2 | 2 | 5 | Upgrade
|
| Market Cap Growth | - | -33.75% | -54.33% | 145.49% | 148.64% | 14.19% | 16.82% | 72.82% | 29.41% | -65.96% | 66.68% | Upgrade
|
| Enterprise Value | 7 | 11 | 17 | 38 | 24 | 18 | 19 | 19 | 18 | 16 | 19 | Upgrade
|
| PE Ratio | -4.83 | -290.69 | 3.89 | 4.08 | 3.24 | 3.17 | 6.90 | 1.71 | 2.42 | 2.44 | 40.23 | Upgrade
|
| PS Ratio | 0.09 | 0.20 | 0.27 | 0.51 | 0.25 | 0.11 | 0.11 | 0.09 | 0.05 | 0.05 | 0.16 | Upgrade
|
| PB Ratio | 0.31 | 0.52 | 0.80 | 2.28 | 2.19 | 2.83 | -0.90 | -0.68 | -0.28 | -0.19 | -0.52 | Upgrade
|
| P/FCF Ratio | 23.04 | 8.86 | 4.14 | 11.86 | 11.83 | -62.23 | 5.09 | 57.32 | -3.30 | -5.15 | 3.11 | Upgrade
|
| P/OCF Ratio | 20.27 | 8.02 | 3.65 | 10.71 | 9.94 | 16.32 | 4.01 | 10.11 | -3.91 | -15.88 | 2.81 | Upgrade
|
| EV/Sales Ratio | 0.12 | 0.22 | 0.30 | 0.61 | 0.46 | 0.36 | 0.44 | 0.41 | 0.42 | 0.43 | 0.56 | Upgrade
|
| EV/EBITDA Ratio | -114.38 | 8.63 | 5.94 | 5.77 | 7.62 | 5.14 | 8.87 | 5.55 | 7.13 | 11.93 | 10.85 | Upgrade
|
| EV/EBIT Ratio | -13.17 | 75.94 | 8.47 | 6.58 | 10.08 | 6.62 | 10.60 | 6.27 | 8.32 | 17.11 | 13.98 | Upgrade
|
| EV/FCF Ratio | 29.22 | 10.07 | 4.62 | 13.96 | 21.37 | -206.65 | 20.65 | 273.45 | -25.01 | -45.88 | 11.15 | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.14 | 0.11 | 0.42 | 1.84 | 6.81 | -2.78 | -2.57 | -1.88 | -1.53 | -1.39 | Upgrade
|
| Debt / EBITDA Ratio | -29.15 | 2.05 | 0.73 | 0.90 | 3.53 | 3.73 | 6.79 | 4.43 | 6.35 | 10.64 | 8.08 | Upgrade
|
| Debt / FCF Ratio | 9.12 | 2.39 | 0.57 | 2.18 | 9.90 | -149.94 | 15.81 | 218.01 | -22.27 | -40.93 | 8.31 | Upgrade
|
| Quick Ratio | 0.77 | 1.21 | 0.99 | 0.66 | 0.46 | 0.40 | 0.26 | 0.41 | 0.34 | 0.27 | 0.27 | Upgrade
|
| Current Ratio | 2.93 | 3.39 | 3.16 | 1.95 | 1.26 | 1.14 | 0.75 | 1.13 | 1.02 | 0.79 | 0.79 | Upgrade
|
| Asset Turnover | 2.38 | 1.99 | 2.23 | 2.50 | 2.30 | 2.53 | 3.00 | 3.09 | 3.00 | 3.23 | 2.91 | Upgrade
|
| Interest Coverage | -226.00 | 3.00 | 18.37 | 22.59 | 6.01 | 4.29 | 1.83 | 4.10 | 2.22 | 0.95 | 1.40 | Upgrade
|
| Return on Equity (ROE) | -2.07% | -0.18% | 20.66% | 55.90% | 67.71% | 89.17% | -12.97% | -39.57% | -11.50% | -7.89% | -1.29% | Upgrade
|
| Return on Assets (ROA) | -1.50% | -0.13% | 15.20% | 31.50% | 17.90% | 8.53% | 4.66% | 15.44% | 6.80% | 6.32% | 1.13% | Upgrade
|
| Return on Capital (ROIC) | -3.28% | -0.19% | 14.08% | 31.45% | 18.44% | 15.12% | 12.27% | 43.17% | 23.24% | 16.02% | 20.53% | Upgrade
|
| Earnings Yield | -6.70% | -0.34% | 25.73% | 24.53% | 30.87% | 31.54% | 14.49% | 58.47% | 41.27% | 40.97% | 2.49% | Upgrade
|
| FCF Yield | 4.34% | 11.29% | 24.16% | 8.43% | 8.45% | -1.61% | 19.65% | 1.74% | -30.28% | -19.40% | 32.16% | Upgrade
|
| Buyback Yield / Dilution | -0.50% | 7.34% | -0.65% | -3.07% | -5.31% | 2.41% | -0.48% | -42.39% | 27.89% | -38.65% | 0.23% | Upgrade
|
| Total Shareholder Return | -0.50% | 7.34% | -0.65% | -3.07% | -5.31% | 2.41% | -0.48% | -42.39% | 27.89% | -38.65% | 0.23% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.